Peritoneal Surface Malignancies
Peritoneal carcinomatosis was once considered an untreatable end-stage disease. Today, with cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), selected patients can achieve long-term survival and even cure.
Key procedures
- Complete cytoreductive surgery (CRS)
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Peritonectomy procedures
- Multivisceral resections
Patient outcomes
15 years of experience in peritoneal carcinomatosis management. National reference centre (CSUR) for peritoneal surface malignancies in Spain. 50–60 cases per year.